Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Phillipou

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Biochemical Journal|July 4, 2023
Photoaffinity labelling displacement assay using multiple recombinant protein domainsDavid J Fallon, Alex Phillipou, Christopher J Schofield, et al.
ACS Medicinal Chemistry Letters|September 22, 2023
Design and Characterization of 1,3-Dihydro-2<i>H</i>-benzo[<i>d</i>]azepin-2-ones as Rule-of-5 Compliant Bivalent BET InhibitorsPaul Bamborough, Chun-Wa Chung, Nicole C Goodwin, et al.
Journal of Medicinal Chemistry|July 22, 2020
GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) ProteinsRobert J Watson, Paul Bamborough, Heather Barnett, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 30, 2021
One-Step Synthesis of Photoaffinity Probes for Live-Cell MS-Based ProteomicsDavid J Fallon, Stephanie Lehmann, Chun-Wa Chung, et al.
Journal of Medicinal Chemistry|December 30, 2025
BET Isoform Selectivity through Diverse Linkers for Bivalent Inhibitors: GSK785, a BRD2/4-Selective Bivalent BET InhibitorFrancesco Rianjongdee, Stephen J Atkinson, Paul Bamborough, et al.
ACS Medicinal Chemistry Letters|August 20, 2021
Optimization of Naphthyridones into Selective TATA-Binding Protein Associated Factor 1 (TAF1) Bromodomain InhibitorsMichael A Clegg, Natalie H Theodoulou, Paul Bamborough, et al.
Journal of Medicinal Chemistry|November 15, 2023
Structure-Guided Design of a Domain-Selective Bromodomain and Extra Terminal N-Terminal Bromodomain Chemical ProbeErin Bradley, Lucia Fusani, Chun-Wa Chung, et al.
Journal of Medicinal Chemistry|July 12, 2021
Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening HitFrancesco Rianjongdee, Stephen J Atkinson, Chun-Wa Chung, et al.
Journal of Medicinal Chemistry|February 29, 2020
Targeting the Regulatory Site of ER Aminopeptidase 1 Leads to the Discovery of a Natural Product Modulator of Antigen PresentationJohn Liddle, Jonathan P Hutchinson, Semra Kitchen, et al.
Journal of Medicinal Chemistry|July 13, 2021
Fragment-based Scaffold Hopping: Identification of Potent, Selective, and Highly Soluble Bromo and Extra Terminal Domain (BET) Second Bromodomain (BD2) InhibitorsJonathan T Seal, Stephen J Atkinson, Paul Bamborough, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Biochemical Journal|July 4, 2023
Photoaffinity labelling displacement assay using multiple recombinant protein domainsDavid J Fallon, Alex Phillipou, Christopher J Schofield, et al.
ACS Medicinal Chemistry Letters|September 22, 2023
Design and Characterization of 1,3-Dihydro-2<i>H</i>-benzo[<i>d</i>]azepin-2-ones as Rule-of-5 Compliant Bivalent BET InhibitorsPaul Bamborough, Chun-Wa Chung, Nicole C Goodwin, et al.
Journal of Medicinal Chemistry|July 22, 2020
GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) ProteinsRobert J Watson, Paul Bamborough, Heather Barnett, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 30, 2021
One-Step Synthesis of Photoaffinity Probes for Live-Cell MS-Based ProteomicsDavid J Fallon, Stephanie Lehmann, Chun-Wa Chung, et al.
Journal of Medicinal Chemistry|December 30, 2025
BET Isoform Selectivity through Diverse Linkers for Bivalent Inhibitors: GSK785, a BRD2/4-Selective Bivalent BET InhibitorFrancesco Rianjongdee, Stephen J Atkinson, Paul Bamborough, et al.
ACS Medicinal Chemistry Letters|August 20, 2021
Optimization of Naphthyridones into Selective TATA-Binding Protein Associated Factor 1 (TAF1) Bromodomain InhibitorsMichael A Clegg, Natalie H Theodoulou, Paul Bamborough, et al.
Journal of Medicinal Chemistry|November 15, 2023
Structure-Guided Design of a Domain-Selective Bromodomain and Extra Terminal N-Terminal Bromodomain Chemical ProbeErin Bradley, Lucia Fusani, Chun-Wa Chung, et al.
Journal of Medicinal Chemistry|July 12, 2021
Discovery of a Highly Selective BET BD2 Inhibitor from a DNA-Encoded Library Technology Screening HitFrancesco Rianjongdee, Stephen J Atkinson, Chun-Wa Chung, et al.
Journal of Medicinal Chemistry|February 29, 2020
Targeting the Regulatory Site of ER Aminopeptidase 1 Leads to the Discovery of a Natural Product Modulator of Antigen PresentationJohn Liddle, Jonathan P Hutchinson, Semra Kitchen, et al.
Journal of Medicinal Chemistry|July 13, 2021
Fragment-based Scaffold Hopping: Identification of Potent, Selective, and Highly Soluble Bromo and Extra Terminal Domain (BET) Second Bromodomain (BD2) InhibitorsJonathan T Seal, Stephen J Atkinson, Paul Bamborough, et al.
Pageof 2